108 related articles for article (PubMed ID: 34698976)
21. Evaluation of a crosswalk between the European Quality of Life Five Dimension Five Level and the Menopause-Specific Quality of Life questionnaire.
Coon C; Bushmakin A; Tatlock S; Williamson N; Moffatt M; Arbuckle R; Abraham L
Climacteric; 2018 Dec; 21(6):566-573. PubMed ID: 30295111
[TBL] [Abstract][Full Text] [Related]
22. EQ-5D-5L Slovenian population norms.
Prevolnik Rupel V; Ogorevc M
Health Qual Life Outcomes; 2020 Oct; 18(1):333. PubMed ID: 33028345
[TBL] [Abstract][Full Text] [Related]
23. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
24. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
25. Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?
Luo N; Cheung YB; Ng R; Lee CF
Health Qual Life Outcomes; 2015 Oct; 13():166. PubMed ID: 26438167
[TBL] [Abstract][Full Text] [Related]
26. EQ-5D-5L Bulgarian population norms.
Encheva M; Djambazov S; Vekov T; Golicki D
Eur J Health Econ; 2020 Nov; 21(8):1169-1178. PubMed ID: 32813084
[TBL] [Abstract][Full Text] [Related]
27. Which approach is better in eliciting health state utilities from breast cancer patients? Evidence from mainland China.
Li S; Wang M; Liu L; Chen G
Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12965. PubMed ID: 30499193
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set.
Grochtdreis T; Dams J; König HH; Konnopka A
Eur J Health Econ; 2019 Aug; 20(6):933-944. PubMed ID: 31030292
[TBL] [Abstract][Full Text] [Related]
29. Self-reported symptoms among participants in a population-based screening program.
Larsen M; Lilleborge M; Vigeland E; Hofvind S
Breast; 2020 Dec; 54():56-61. PubMed ID: 32927237
[TBL] [Abstract][Full Text] [Related]
30. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
31. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
34. Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review.
Zhou T; Guan H; Wang L; Zhang Y; Rui M; Ma A
Front Public Health; 2021; 9():675523. PubMed ID: 34268287
[No Abstract] [Full Text] [Related]
35. Comparing the EQ-5D-5L crosswalks and value sets for England, the Netherlands and Spain: Exploring their impact on cost-utility results.
Ben Â; Finch AP; van Dongen JM; de Wit M; van Dijk SEM; Snoek FJ; Adriaanse MC; van Tulder MW; Bosmans JE
Health Econ; 2020 May; 29(5):640-651. PubMed ID: 32059078
[TBL] [Abstract][Full Text] [Related]
36. Quality-of-life effects of screening mammography in Norway.
Zahl PH; Kalager M; Suhrke P; Nord E
Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life and utility scores of patients with breast neoplasms in China: A multicenter cross-sectional survey.
Wang L; Shi JF; Zhu J; Huang HY; Bai YN; Liu GX; Liao XZ; Mao AY; Ren JS; Sun XJ; Guo LW; Fang Y; Zhou Q; Ma HM; Xing XJ; Zhu L; Song BB; Du LB; Mai L; Liu YQ; Ren Y; Lan L; Zhou JY; Qi X; Sun XH; Lou PA; Wu SL; Li N; Zhang K; He J; Dai M;
Breast; 2018 Jun; 39():53-62. PubMed ID: 29597131
[TBL] [Abstract][Full Text] [Related]
38. Health related quality of life in different states of breast cancer.
Lidgren M; Wilking N; Jönsson B; Rehnberg C
Qual Life Res; 2007 Aug; 16(6):1073-81. PubMed ID: 17468943
[TBL] [Abstract][Full Text] [Related]
39. Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged "no-problems".
Murasawa H; Sugiyama T; Matsuoka Y; Okabe T; Wakumoto Y; Tanaka N; Sugimoto M; Oyama M; Fujimoto K; Horie S; Funagoshi M; Arakawa I; Noto S; Shimozuma K
Qual Life Res; 2020 Mar; 29(3):755-763. PubMed ID: 31583618
[TBL] [Abstract][Full Text] [Related]
40. Depression symptoms and health-related quality of life among patients with metastatic breast cancer in programme of palliative cancer care.
Slovacek L; Slovackova B; Slanska I; Petera J; Priester P; Filip S; Kopecky J
Neoplasma; 2009; 56(6):467-72. PubMed ID: 19873686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]